These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10409307)
1. Puromycin aminonucleoside nephrosis results in a marked increase in fractional clearance of albumin. Osicka TM; Hankin AR; Comper WD Am J Physiol; 1999 Jul; 277(1):F139-45. PubMed ID: 10409307 [TBL] [Abstract][Full Text] [Related]
2. Protein degradation during renal passage in normal kidneys is inhibited in experimental albuminuria. Osicka TM; Comper WD Clin Sci (Lond); 1997 Jul; 93(1):65-72. PubMed ID: 9279205 [TBL] [Abstract][Full Text] [Related]
3. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats. Olson JL; Rennke HG; Venkatachalam MA Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051 [TBL] [Abstract][Full Text] [Related]
4. Do large pores in the glomerular capillary wall account for albuminuria in nephrotic states? Vuchkova J; Koltun M; Greive K; Comper WD Am J Physiol Renal Physiol; 2014 Sep; 307(5):F525-32. PubMed ID: 24990894 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis. Hjalmarsson C; Lidell ME; Haraldsson B Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules. Bohrer MP; Baylis C; Robertson CR; Brenner BM; Troy JL; Willis WT J Clin Invest; 1977 Jul; 60(1):152-61. PubMed ID: 874080 [TBL] [Abstract][Full Text] [Related]
7. Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis. Greive KA; Nikolic-Paterson DJ; Guimarães MA; Nikolovski J; Pratt LM; Mu W; Atkins RC; Comper WD Am J Pathol; 2001 Sep; 159(3):1159-70. PubMed ID: 11549609 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside. Schwartz MM; Sharon Z; Pauli BU; Lewis EJ Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977 [TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat. Kimura K; Endou H; Sakai F J Toxicol Sci; 1979 Feb; 4(1):1-10. PubMed ID: 480401 [TBL] [Abstract][Full Text] [Related]
10. Renal processing of serum proteins in an albumin-deficient environment: an in vivo study of glomerulonephritis in the Nagase analbuminaemic rat. Osicka TM; Strong KJ; Nikolic-Paterson DJ; Atkins RC; Jerums G; Comper WD Nephrol Dial Transplant; 2004 Feb; 19(2):320-8. PubMed ID: 14736954 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis. Khong TF; Fraser S; Katerelos M; Paizis K; Hill PA; Power DA Kidney Int; 2000 Sep; 58(3):1098-107. PubMed ID: 10972674 [TBL] [Abstract][Full Text] [Related]
12. Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis. Whiteside CI; Cameron R; Munk S; Levy J Am J Pathol; 1993 May; 142(5):1641-53. PubMed ID: 8494056 [TBL] [Abstract][Full Text] [Related]
13. Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis. Groggel GC; Hovingh P; Border WA; Linker A Am J Pathol; 1987 Sep; 128(3):521-7. PubMed ID: 2443012 [TBL] [Abstract][Full Text] [Related]
14. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis]. Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862 [TBL] [Abstract][Full Text] [Related]
15. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation. Santos AM; Pomin VH; Stelling MP; Guimarães MA; Cardoso LR; Mourão PA Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817 [TBL] [Abstract][Full Text] [Related]
16. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases. Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353 [TBL] [Abstract][Full Text] [Related]
17. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode. Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459 [TBL] [Abstract][Full Text] [Related]
18. A morphometric, biochemical and histochemical comparison of puromycin aminonucleoside and hyperalbuminaemic induced proteinurias in the female Wistar rat. Lawrence GM; Brewer DB J Pathol; 1983 Feb; 139(2):115-40. PubMed ID: 6827398 [TBL] [Abstract][Full Text] [Related]
19. A study of VEGF and its receptors in two rat models of proteinuria. Kanellis J; Levidiotis V; Khong T; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA Nephron Physiol; 2004; 96(1):P26-36. PubMed ID: 14752241 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis. Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]